Home / BUSINESS / USFDA completes inspection at Indoco Remedies’ Goa facility

USFDA completes inspection at Indoco Remedies’ Goa facility

US Food and Drug Administration (USFDA) has inspected Indoco Remedies’ Sterile facility (Plant II) and Solid Dosages facility (Plant III) situated at Goa from November 14 to 21, 2018. The inspection concluded with Indoco receiving 2 minor observations, none of which are repeat in nature.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Please share this news